LGVN
USDLongeveron Inc. Class A Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.820
Hoch
$0.820
Tief
$0.800
Volumen
0.38M
Unternehmensfundamentaldaten
Marktkapitalisierung
16.8M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.95M
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
Ähnliche Aktien
IBM
International Business Machines Corporation
CPSS
Consumer Portfolio Services Inc.
MSN
Emerson Radio Corporation
AWF
Alliancebernstein Global High Income Fund
SKGRW
SK Growth Opportunities Corporation Warrant
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.